Taken together, the results indicate that KIFC1-S26 phosphorylation drives local and distant tumor recurrence through increased CIN, and either VE-822 or CW069 treatment prevented tumor recurrence after etoposide treatment. Here, KIFC1 is linked to neoplasm.